Journal article
Vasopressin in Alzheimer's disease: A study of postmortem brain concentrations
Abstract
Vasopressin (AVP) and its analogues are reported to improve learning- and memory-related performance in experimental animals, and perhaps also in humans. Memory impairment is a clinical hallmark of the dementing disorder, Alzheimer's disease. We have examined AVP concentrations in postmortem brain tissue from 12 patients with histologically confirmed Alzheimer's disease and 13 control subjects. AVP was measured by a highly specific and …
Authors
Mazurek MF; Bed MF; Bird ED; Martin JB
Journal
Annals of Neurology, Vol. 20, No. 6, pp. 665–670
Publisher
Wiley
Publication Date
December 1986
DOI
10.1002/ana.410200603
ISSN
0364-5134